Previous 10 | Next 10 |
home / stock / pfe / pfe articles
The FDA has allowed Florida to import prescription drugs from Canada, potentially altering the landscape of how Americans access and affo...
Around 15% of Americans said they were planning to participate this year in Dry January — a month of abstinence from alcohol — according to a s...
In a year when equity markets rallied strongly, short sellers — traders who position for losses on assets — had an extremely tough time in 2023...
During the last week of 2023, AstraZeneca PLC (NASDAQ: AZN) agreed to acquire Chinese cancer therapy developer Gracell Biotechnologies Inc. as...
Just as large pharma companies prepare a showdown with Medicare's newfound power to negotiate down drug prices, several major drug companies ar...
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. The forthcoming year will provide the first...
CytoSorbents Corporation (NASDAQ: CTSO) released an update on the initial data analysis of primary safety and effectiveness endpoints and the ...
COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023. ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-24 10:13:00 ET If there's one thing healthcare giant Pfizer (NYSE: PFE) really needs right now, it's a compelling growth catalyst. This year, the company isn't expecting much in the way of growth and investors are unsure about how strong its long-term prospects are, which ...
2024-07-24 10:08:31 ET DENVER, Colo., Jul 24, 2024 ( 247marketnews.com )- Sangamo Therapeutics, Inc. (Nasdaq: SGMO ) expounded on Pfizer’s (NYSE: PFE ) positive topline results from their Phase 3 AFFINE trial (NCT04370054) evaluating giroctocogene fitelparvovec, an invest...
2024-07-24 09:00:21 ET Pfizer Inc. (PFE) declaring a stock dividend of $0.42 per share on Ex-Date : July 25, 2024. Shareholders on record as of July 26, 2024 are eligible for the dividend. The payment date is scheduled for September 03, 2024, and the declaration was officially made ...